But she said nothing works as well for her as Wegovy
For payers, the expectation should be that international reference pricing will eventually become embedded in the American system
Researchers optimizing their protocols should track: Body composition: Use DEXA scans, bioimpedance devices, or at minimum waist/hip measurements to distinguish fat loss from lean mass loss Resting heart rate: Particularly important with retatrutide due to the glucagon-mediated heart rate increase Blood pressure: Both peptides lower blood pressure, which is beneficial but can cause dizziness if the drop is too rapid Fasting blood glucose: Especially relevant for those managing pre-diabetes or type 2 diabetes Liver enzymes: For anyone with suspected or confirmed fatty liver disease Energy levels and sleep quality: Subjective but important indicators of protocol tolerance The GLP-1 progress tracking tools available through SeekPeptides help members monitor these metrics systematically rather than relying on memory or sporadic tracking
Lilly removed this from the slide deck, but I managed to snag a picture at the presentation We can see the women in the trial were already at 30.8% weight loss at 80 weeks on the max dose with the 9mg dose only 2% behind and both still losing weight
Skov J, Pedersen M, Holst JJ, Madsen B, Goetze JP, Rittig S, et al
Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, et al
